[Skip to Content]
[Skip to Content Landing]
July 28, 1956


JAMA. 1956;161(13):1275. doi:10.1001/jama.1956.02970130063021

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The Committee on Fetus and Newborn of the American Academy of Pediatrics has prepared the following statement on the use of oxygen in premature and small infants. Prepared by the Committee on the Fetus and Newborn Infant of the American Academy of Pediatrics.

STATEMENT CONCERNING THE USE OF OXYGEN IN THE TREATMENT OF PREMATURE INFANTS  The accumulated evidence definitely incriminates the excessive use of oxygen as a major factor in the cause of retrolental fibroplasia in premature infants. "Excessive use" implies concentrations of more than 40% or the prolongation of administration after the indication for its use has passed. It is possible that even short periods of administration of higher concentration may be harmful.On the other hand, the intelligent use of oxygen can be the means of saving the lives of hypoxic, dyspneic, and cyanotic babies. It would be unwise to arbitrarily deny adequate oxygen (and

First Page Preview View Large
First page PDF preview
First page PDF preview